Clinical Trials for Hypereosinophilic Syndrome

Find clinical trials for hypereosinophilic syndrome. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

NCT ID: NCT00044304

This clinical trial is studying the use of a medication called imatinib mesylate (Gleevec) to treat patients with a condition known as myeloid hypereosinophilic syndrome (HES). HES is characterized...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

NCT ID: NCT00091871

This clinical trial is studying a condition called familial hypereosinophilia (FE), which is a hereditary form of hypereosinophilic syndrome (HES). In HES, a type of white blood cell called eosinop...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

NCT ID: NCT06477653

This clinical trial is testing a medication called dupilumab to see if it can help people with Hypereosinophilic Syndrome (HES) who are not fully responding to their current treatments. HES is a co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT ID: NCT05334368

This clinical trial is studying a new treatment called depemokimab for adults with Hypereosinophilic Syndrome (HES), a condition where the body produces too many eosinophils, a type of white blood ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Pavia, Lombardia, Italy, Napoli, Campania, Italy +125 more

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT ID: NCT03801434

This clinical trial is studying a medication called ruxolitinib to see how well it works for patients with hypereosinophilic syndrome or other related blood disorders. These conditions are characte...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, Portland, Oregon, United States +2 more

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

NCT ID: NCT04018118

The COHESion study is a clinical trial focused on understanding a condition called hypereosinophilia (HE) and a related group of disorders known as hypereosinophilic syndromes (HES). These conditio...

Recruiting

Type: observational Locations: Lille, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions